CClinicalTrials.gg
RecruitingNCT06639789PERB12Updated Oct 15, 2024

Effect of a New Formulation of Vitamin B12 on Physical and Mental

An interventional study of Vitamin B12 (B12) and PLACEBO (PLA) in Performance Enhancing Product Use, sponsored by Francisco Javier Martínez Noguera. Recruiting at 1 site in Spain. Open to male participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-15.

Sponsored by Francisco Javier Martínez Noguera · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Jul 2024; still recruiting 2 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Male
01

Study summary

This clinical study evaluates the effect of acute intake of a new vitamin B12 formulation on anaerobic and cognitive performance variables. One of the limiting factors for the potential beneficial effects of vitamin B12 is its bioavailability. This new formula improves this aspect, so that by improving plasma levels of B12 we will be able to relate whether this situation may be related to improved performance or cognitive tasks.

Read the detailed description

Participants

All participants were informed about the procedures and provided signed informed consent. The study was conducted in accordance with the guidelines of the Declaration of Helsinki Declaration for Research Involving Human Subjects and the protocol was approved by the Institutional Review/Ethics Committee of the Catholic University of Murcia (Code: CE052416).

Study design

Randomized, double-blind, placebo-controlled, crossover clinical trial with 2 study groups (vitamin B12 and placebo). Cyclists were instructed to take the supplement (vitamin B12 or placebo) with breakfast on the three days before the tests and 3h before the test day, and to continue with their usual diet and training programme. Subjects in both groups were instructed not to consume vitamin B12-rich foods for 7 days before and during the study. Between each intervention (B12 and Placebo) there was a 7-day washout period.

Procedures

Participants visited the laboratory on three occasions. Visit 1 consisted of a medical examination and a blood draw to determine health status. At visits 2 and 3, a 24-hour diet reminder and a Wingate test, mental fatigue test and venous blood draw were performed. The sports nutritionist prescribed a standardized breakfast before each testing session (visits 2 and 3).

Pre- and post-evaluation test

Visit 1:

Health status blood test: A general blood test will be performed both pre- and post-supplementation. The blood will be drawn through a vein (fasting).

Medical examination: A medical history of family and personal history, an electrocardiogram (ECG) at rest and a medical examination (auscultation, blood pressure, etc.) will be carried out to certify that the person is healthy and does not present a risk to participate in the study (Fasting).

Body composition by absorptiometric densitometry (DXA): A body composition test will be performed using the double energy absorptiometric densitometry technique (X-rays), with the aim of determining parameters of fat mass, fat-free mass and fat percentage. In addition, anthropometry will also be used to determine changes in body composition (fat and muscle mass) (Fasting).

Visits 2 and 3:

Anaerobic power and mechanical power output: After a standardised breakfast, a Wingate test was performed on a cycle ergometer. The Wingate test (WAnT) consisted of a 30 s sprint on a cycle ergometer (Monark Ergomedic 894E Peak Bike, Vansbro, Sweden). Breaking strength was held constant at 7.5% of each individual's body mass. All participants were verbally encouraged to pedal as fast as possible throughout the sprint.

Mental fatigue test: All participants will be tested for the evaluation of reaction time to a sequence of lights set by the investigator before and after the performance test.

Biochemical markers: A venous blood draw will be performed by medical personnel before and after the performance test, in which vitamin B12, creatine kinase and lactate dehydrogenase levels will be analyzed.

All data of the subjects who participated in the study were stored in a computer system with a security key. In addition, some of the data was also recorded on paper and kept under lock and key, accessible only to the researchers of this project.

02

Conditions studied

  • Performance Enhancing Product Use

Keywords

  • Anaerobic performance
  • Power
  • Mental fatigue
  • Vitamins
  • Recovery
03

In context

Lead sponsor

Francisco Javier Martínez Noguera is the lead sponsor of 6 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male cyclists who have competed in both junior and amateur categories.
  • Cycling between 6-15 hours of training per week.
  • BMI between 18-25 kg/m2.

Exclusion criteria

Exclusion Criteria:

  • Smokers or regular alcohol drinkers.
  • Persons suffering from a metabolic, cardiorespiratory or digestive pathology or anomaly.

digestive system.

  • People who have suffered an injury in the last 6 months that limits the performance of the study tests. of the study tests.
  • People taking supplements or medication in the 2 weeks before the start of the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
18 participants (estimated)

Study arms

  • Experimental
    Vitamin B12 (B12)

    Subjects in this group will intake 1 mg/day of vitamin B12 three days before the tests.

    Dietary Supplement: Vitamin B12 (B12)

  • Placebo comparator
    PLACEBO (PLA)

    Subjects in this group will intake 200 mg/day of microcrystalline cellulose three days before the tests.

    Dietary Supplement: PLACEBO (PLA)

Interventions

  • Dietary supplementVitamin B12 (B12)

    The new formulation of vitamin B12 will be ingested 3 days before and on the day of testing (3 hours before).

  • Dietary supplementPLACEBO (PLA)

    The placebo will be ingested 3 days before and the same day of the tests (3 hours before).

06

What researchers measure

Primary outcomes

  1. Wingate test

    This test consists of 5 efforts of 30 seconds at maximum intensity with a recovery of 3 minutes on a bike. In this test the peak and average power of each effort and the total average will be evaluated. In addition, the time to maximum peak power and the fatigue index.

    Time frame: Throughout study completion, an average of 3 weeks

Secondary outcomes

  1. Mental fatigue test

    In this test, we will measure the speed of reaction in the resolution of a sequence of lights set by the researcher before and after the end of the performance test.

    Time frame: Throughout study completion, an average of 3 weeks

  2. Biochemical markers

    Vitamin B12, creatine kinase and lactate dehydrogenase concentrations are also measured before and after the performance tests.

    Time frame: Throughout study completion, an average of 3 weeks

  3. Sleep Quality Questionnaire (Pittsburgh)

    The questionnaire will be carried out 3 days before and one day after the performance tests.

    Time frame: Throughout study completion, an average of 3 weeks

07

Study locations

1 of 1 sites recruiting
  • Research Center for High Performance Sport. Catholic University of Murcia
    La Ñora, Murcia 30830, Spain
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06639789
Lead sponsor
Francisco Javier Martínez Noguera
Collaborators
Universidad Católica San Antonio de Murcia
Responsible party
Francisco Javier Martínez Noguera (PhD (Head of the nutrition area of the Research Center for High Performance Sport), Universidad Católica San Antonio de Murcia) — Sponsor-investigator
First posted
Oct 15, 2024
Start date
Jul 1, 2024
Primary completion
Nov 30, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Oct 15, 2024

Study contacts

Francisco Javier FJ Martínez Noguera, PhD
Contact
fjmartinez3@ucam.edu
(+34) 968278566
Cristian C Marín Pagán, PhD
Contact
cmarin@ucam.edu
(+34) 968278566
Francisco Javier J Martínez Noguera
study chair · Research Center for High Performance Sport. Catholic University of Murcia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion